Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension
- PMID: 11015616
- DOI: 10.1152/physrev.2000.80.4.1337
Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension
Abstract
Chronic pulmonary hypertension is a serious complication of a number of chronic lung and heart diseases. In addition to vasoconstriction, its pathogenesis includes injury to the peripheral pulmonary arteries leading to their structural remodeling. Increased pulmonary vascular synthesis of an endogenous vasodilator, nitric oxide (NO), opposes excessive increases of intravascular pressure during acute pulmonary vasoconstriction and chronic pulmonary hypertension, although evidence for reduced NO activity in pulmonary hypertension has also been presented. NO can modulate the degree of vascular injury and subsequent fibroproduction, which both underlie the development of chronic pulmonary hypertension. On one hand, NO can interrupt vascular wall injury by oxygen radicals produced in increased amounts in pulmonary hypertension. NO can also inhibit pulmonary vascular smooth muscle and fibroblast proliferative response to the injury. On the other hand, NO may combine with oxygen radicals to yield peroxynitrite and other related, highly reactive compounds. The oxidants formed in this manner may exert cytotoxic and collagenolytic effects and, therefore, promote the process of reparative vascular remodeling. The balance between the protective and adverse effects of NO is determined by the relative amounts of NO and reactive oxygen species. We speculate that this balance may be shifted toward more severe injury especially during exacerbations of chronic diseases associated with pulmonary hypertension. Targeting these adverse effects of NO-derived radicals on vascular structure represents a potential novel therapeutic approach to pulmonary hypertension in chronic lung diseases.
Similar articles
-
The upregulation of endothelial nitric oxide synthase and urotensin-II is associated with pulmonary hypertension and vascular diseases in rats produced by aortocaval shunting.Heart Vessels. 2004 Mar;19(2):81-8. doi: 10.1007/s00380-003-0739-3. Heart Vessels. 2004. PMID: 15042392
-
[Pulmonary hypertension: the role of nitric oxide in adults].Rev Esp Anestesiol Reanim. 2001 Dec;48(10):457-9. Rev Esp Anestesiol Reanim. 2001. PMID: 11792299 Review. Spanish.
-
Chronic inhaled nitric oxide: effects on pulmonary vascular endothelial function and pathology in rats.J Appl Physiol (1985). 1996 Jan;80(1):252-60. doi: 10.1152/jappl.1996.80.1.252. J Appl Physiol (1985). 1996. PMID: 8847312
-
Role of inducible nitric oxide synthase in the pulmonary vascular response to birth-related stimuli in the ovine fetus.Circ Res. 2001 Apr 13;88(7):721-6. doi: 10.1161/hh0701.088683. Circ Res. 2001. PMID: 11304495
-
NO in the lung.Respir Physiol. 1995 Aug;101(2):109-20. doi: 10.1016/0034-5687(95)00016-7. Respir Physiol. 1995. PMID: 8570913 Review.
Cited by
-
Pulmonary Hypertension Subtypes and Mortality in CKD.Am J Kidney Dis. 2020 May;75(5):713-724. doi: 10.1053/j.ajkd.2019.08.027. Epub 2019 Nov 12. Am J Kidney Dis. 2020. PMID: 31732231 Free PMC article.
-
Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.Am J Respir Crit Care Med. 2007 Dec 1;176(11):1138-45. doi: 10.1164/rccm.200707-1121OC. Epub 2007 Sep 13. Am J Respir Crit Care Med. 2007. PMID: 17872487 Free PMC article.
-
Analysis of responses to the Rho-kinase inhibitor Y-27632 in the pulmonary and systemic vascular bed of the rat.Am J Physiol Heart Circ Physiol. 2010 Jul;299(1):H184-92. doi: 10.1152/ajpheart.00181.2009. Epub 2010 Apr 30. Am J Physiol Heart Circ Physiol. 2010. PMID: 20435851 Free PMC article.
-
Κ-opioid receptor stimulation improves endothelial function in hypoxic pulmonary hypertension.PLoS One. 2013 May 7;8(5):e60850. doi: 10.1371/journal.pone.0060850. Print 2013. PLoS One. 2013. PMID: 23667430 Free PMC article.
-
Simvastatin and dehydroepiandrosterone sulfate effects against hypoxic pulmonary hypertension are not additive.Physiol Res. 2022 Dec 16;71(6):801-810. doi: 10.33549/physiolres.934913. Epub 2022 Nov 25. Physiol Res. 2022. PMID: 36426885 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical